Dulaglutide
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Company n/r · Phase 4 · Terminated · Enrollment 28
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Dulaglutide Arm | n/r | n/r | n/r | n/r |
| Placebo Arm | n/r | n/r | n/r | n/r |
Not shown
- Dulaglutide Arm: endpoint not reported
- Placebo Arm: endpoint not reported